ESR2 and prostate carcinoma: In one of the earliest studies, the tumor repressive role of ERβ in prostate cancer was demonstrated through its adenovirus-driven expression in ERα-negative DU145 prostate cancer cells that caused a significant reduction of invasion in a matrigel-coated transwell assay [47].